Regorafenib (Regorafenib) medical insurance reimbursement conditions and how much it costs
Regorafenib(Regorafenib)The original drug has been launched in China and has entered the scope of Class B medical insurance. The medical insurance reimbursement conditions are limited to second-line treatment of hepatocellular carcinoma and transplantation. Patients who are not eligible for third-line treatment of metastatic colorectal cancer and third-line treatment of gastrointestinal stromal tumors need to pay for it at their own expense. Different regions have different reimbursement ratios, and the price after reimbursement is different. SpecificationsThe price of each box of 40mg*28 tablets is around RMB 5,000.

RegofenibThe benefits of regorafenib are considered to outweigh its risks, and in colorectal cancer, the benefits of prolonged survival are modest, but the benefits are thought to outweigh the risks in patients who have no other treatment options. Regarding gastrointestinal stromal tumors and hepatocellular carcinoma, the outlook is poor for patients whose disease worsens despite previous treatment. Regofenibhas been shown to slow progression in these patients. For patients with hepatocellular carcinoma, this results in prolonged survival. Hepatocyte side effects can be controlled. The most common side effects are pain, weakness, fatigue, loss of appetite and food intake, hand-foot syndrome, diarrhea, infection, and high blood pressure. The most serious side effects are severe liver damage, bleeding, gastrointestinal perforation, and infection.
RegofenibThe original drug has also been launched overseas. The specifications of the Turkish versionThe price of 40mg*28 tablets per box is around RMB 6,400 (the price may fluctuate due to exchange rates). There are also generic regorafenib drugs produced in other countries, and their drug ingredients are basically the same as those of the original drug. The price of a box of 40mg*90 tablets produced by a Bangladesh pharmaceutical factory is around 2,900 yuan (the price may fluctuate due to exchange rates).
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)